Golden Field Medical launches early screening service for triple gene methylation in breast cancer.

According to a news release from Geni Medical, in response to the shortcomings of traditional screening methods such as lack of accuracy and low compliance, Geni Medical has launched a breast cancer three-gene methylation early screening service, which can achieve non-invasive, painless, and radiation-free early precise screening with a sensitivity of 80.71% and specificity of 92.79%. It can capture tumor signals earlier and significantly improve the early diagnosis rate and convenience of breast cancer screening.